$0.16 EPS Expected for Orthofix Medical Inc. (NASDAQ:OFIX) This Quarter

Brokerages expect Orthofix Medical Inc. (NASDAQ:OFIX) to report $0.16 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Orthofix Medical’s earnings. The lowest EPS estimate is $0.12 and the highest is $0.19. Orthofix Medical posted earnings of ($0.59) per share during the same quarter last year, which indicates a positive year over year growth rate of 127.1%. The firm is scheduled to report its next earnings report on Thursday, August 5th.

On average, analysts expect that Orthofix Medical will report full-year earnings of $0.55 per share for the current fiscal year, with EPS estimates ranging from $0.53 to $0.57. For the next year, analysts anticipate that the company will report earnings of $0.74 per share, with EPS estimates ranging from $0.46 to $1.01. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that follow Orthofix Medical.

Orthofix Medical (NASDAQ:OFIX) last issued its earnings results on Friday, April 30th. The medical device company reported $0.17 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.07 by $0.10. The firm had revenue of $105.59 million during the quarter, compared to analyst estimates of $95.40 million. Orthofix Medical had a negative net margin of 7.11% and a positive return on equity of 1.93%.

Separately, Zacks Investment Research cut Orthofix Medical from a “hold” rating to a “sell” rating in a research report on Thursday, April 29th.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Marshall Wace North America L.P. bought a new position in shares of Orthofix Medical during the 1st quarter worth approximately $25,000. Captrust Financial Advisors raised its stake in shares of Orthofix Medical by 2,623.3% during the 1st quarter. Captrust Financial Advisors now owns 817 shares of the medical device company’s stock worth $35,000 after acquiring an additional 787 shares in the last quarter. Point72 Hong Kong Ltd raised its stake in shares of Orthofix Medical by 57.1% during the 1st quarter. Point72 Hong Kong Ltd now owns 834 shares of the medical device company’s stock worth $36,000 after acquiring an additional 303 shares in the last quarter. Altshuler Shaham Ltd purchased a new stake in shares of Orthofix Medical during the 1st quarter valued at $37,000. Finally, Vantage Consulting Group Inc purchased a new stake in shares of Orthofix Medical during the 4th quarter valued at $75,000. Institutional investors own 96.07% of the company’s stock.

Shares of OFIX opened at $38.09 on Monday. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.66 and a quick ratio of 1.81. The stock has a market cap of $745.04 million, a PE ratio of 113.15, a PEG ratio of 30.86 and a beta of 1.14. The stock has a 50 day simple moving average of $40.59. Orthofix Medical has a fifty-two week low of $28.03 and a fifty-two week high of $48.50.

About Orthofix Medical

Orthofix Medical Inc operates as a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures.

Featured Article: How is diluted EPS different from basic EPS?

Get a free copy of the Zacks research report on Orthofix Medical (OFIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Orthofix Medical (NASDAQ:OFIX)

Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.